A detailed history of Farther Finance Advisors, LLC transactions in Insmed Inc stock. As of the latest transaction made, Farther Finance Advisors, LLC holds 478 shares of INSM stock, worth $33,273. This represents 0.0% of its overall portfolio holdings.

Number of Shares
478
Previous 465 2.8%
Holding current value
$33,273
Previous $30.9 Million 13.11%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$62.0 - $79.01 $806 - $1,027
13 Added 2.8%
478 $34.9 Million
Q2 2024

Jul 31, 2024

BUY
$22.0 - $69.71 $3,300 - $10,456
150 Added 47.62%
465 $30.9 Million
Q1 2024

May 13, 2024

BUY
$25.72 - $29.94 $7,613 - $8,862
296 Added 1557.89%
315 $8.42 Million
Q4 2023

Feb 14, 2024

BUY
$23.42 - $31.74 $6,932 - $9,395
296 Added 1557.89%
315 $9.76 Million
Q1 2023

May 13, 2024

SELL
$16.26 - $21.73 $4,812 - $6,432
-296 Reduced 93.97%
19 $324,000
Q4 2022

Sep 11, 2023

BUY
$16.98 - $23.15 $322 - $439
19 New
19 $380,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.43B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Farther Finance Advisors, LLC Portfolio

Follow Farther Finance Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Farther Finance Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Farther Finance Advisors, LLC with notifications on news.